Monographie - Voriconazole

Última actualización :
19/11/2024

Voriconazole

Factores que influyen sobre la estabilidad

Estructura química

Nombre comercial

Los nombres comerciales son orientativos y los excipientes de la formulación pueden ser distintos dependiendo del país y del laboratorio fabricante.

Candiox	Ecuador
Ekomikane	México
Fusitop	Chile
Vfend	Alemania, Arabia Saudita, Argentina, Australia, Austria, Bélgica, Canadá, Chile, Colombia, Dinamarca, Ecuador, Egipto, Emiratos Árabes Unidos, España, Estados Unidos de América, Finlandia, Francia, Gran Bretaña, Grecia, Hungría, Irán, Irlanda, Islandia, Italia, Japón, Luxemburgo, Malasia, Marruecos, México, Noruega, Nueva Zelanda, Países Bajos, Polonia, Portugal, Rumania, Suecia, Suiza, Túnez, Turquía, Venezuela
Viradep	Chile
Vorazyr	Turquía
Vorcum	Venezuela
Voriole	Chile
Vorix	Turquía
Vorzole	Marruecos
Zivenad	Chile

Bibliografía : Voriconazole

	Tipo	Publicación
1982	periódico	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2017	periódico	Barker B, Feddema S, Rusho WJ, Dengg R. Visual compatibility of vasopressin with other injectable drugs. Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2111	periódico	Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L. Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C. EJHP Science 2006 ; 12, 3: 57-59.
2131	periódico	Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan JE. Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections. Am J Health-Syst Pharm 2006 ; 63: 1423-1426.
2233	periódico	Condie C.K, Tyler L.S, Barker B, Canann D.M. Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery Am J Health-Syst Pharm 2008 ; 65, 5: 454-457.
2247	periódico	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262	periódico	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269	periódico	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3012	periódico	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3087	periódico	Adams, A.I.H., Morimoto, L.N., Meneghini, L.Z., Bergold, A.M. Treatment of invasive fungal infections: Stability of voriconazole infusion solutions in PVC bags. BJID 2008 ; 12, 5: 400-404.
3249	periódico	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3408	periódico	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3566	Laboratorio	Voriconazole (Vfend®) - Summary of Product characteristics. Pfizer 2013
3824	periódico	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3964	periódico	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
3975	póster	Roche M, Simon N, Bourdon F, Dhorne C, Berneron C, Lannoy D, Odou P. Stability of 50 and 100 µg/0,1mL intraocular solutions of voriconazole at 2-8°C. EAHP congress - Cannes 2017
4035	periódico	Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P. Physicochemical stability of voriconazole in elastomeric devices. EJHP 2017 ;0:1-5
4254	periódico	D'Huart E, Vigneron J, Demoré B. Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
4319	periódico	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4528	periódico	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4603	periódico	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4633	periódico	Reber E, Neyer P, Schönenberger K.A, Saxer C, Bernasconi L, Stanga Z, Huber A, Hammerer-Lercher A, Mühlebach S. Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures. Pharmaceutics 2021 ; 13, 1447.
4742	periódico	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.

Mentions Légales